Shorter Regimen Of Bedaquiline Plus Linezolid Noninferior To Standard Treatment For Tuberculosis, Trial Finds

Healio (2/21, Stulpin) reports, “An 8-week boosted regimen of bedaquiline and linezolid was noninferior to standard 24-week treatment for tuberculosis in terms of clinical outcomes, according to the results of a phase 2-3 trial.” These results from the “o...